Resverlogix Expands Phase 2b Clinical Trial for COVID-19 with 1st Site in Brazil and 2nd in Canada
A further five sites in Brazil and a third Canadian site, in Toronto, Ontario, will also be coming on line soon.
© 2023 Frontier Merchant Capital Group. All Rights Reserved.